{"product_id":"bpc-157-tb-500-blend-10mg-10-vial-box","title":"BPC-157 + TB-500 Blend 10\/10mg – 10 Vial Box","description":"\u003ch2\u003eDescription\u003c\/h2\u003e\n\u003ch2\u003eDescription\u003c\/h2\u003e\n\u003cp\u003eBPC-157 is a naturally occurring peptide investigated for its interactions with tissue remodeling pathways and cellular repair mechanisms. Research has examined its observed effects on fibroblast proliferation, tendon and muscle extracellular matrix remodeling, gastrointestinal epithelial integrity, and inflammatory cytokine modulation. TB-500 (TB-4) is a synthetic analogue of Thymosin Beta-4 studied for its interactions with actin sequestration, angiogenesis, and extracellular matrix reorganization. These compounds are frequently investigated in combination for their complementary mechanistic profiles across overlapping tissue remodeling pathways.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor Research Use Only. Not for Human Consumption.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMinimum order quantity: one box (10 vials x 10\/10 mg, 100 mg of each in total).\u003cstrong\u003e\u003cbr\u003e\n\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong data-start=\"1074\" data-end=\"1083\"\u003eNote: \u003c\/strong\u003eProduct images show branded labels for illustration purposes only. All peptides are shipped in wholesale, unbranded packaging. You can see an actual example photo of the peptide vials and container above.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ch2\u003eAdditional information\u003c\/h2\u003e\n\u003ctable class=\"woocommerce-product-attributes shop_attributes\" aria-label=\"Product Details\"\u003e\n\u003ctr class=\"woocommerce-product-attributes-item woocommerce-product-attributes-item--attribute_purity\"\u003e\n\u003cth class=\"woocommerce-product-attributes-item__label\" scope=\"row\"\u003ePurity\u003c\/th\u003e\n\u003ctd class=\"woocommerce-product-attributes-item__value\"\u003e\n\u003cp\u003e≥99.0%\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"woocommerce-product-attributes-item woocommerce-product-attributes-item--attribute_pa_cost-per-vial\"\u003e\n\u003cth class=\"woocommerce-product-attributes-item__label\" scope=\"row\"\u003eCost per vial $\u003c\/th\u003e\n\u003ctd class=\"woocommerce-product-attributes-item__value\"\u003e\n\u003cp\u003e50\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eResearch\u003c\/h2\u003e\n\u003col\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022202X15405950\"\u003eMalinda, Katherine M., et al. \"Thymosin β4 accelerates wound healing.\" \u003ci\u003eJournal of Investigative Dermatology\u003c\/i\u003e 113.3 (1999): 364-368.\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24937047\/\"\u003eCheng, Peng, et al. \"Beneficial effects of thymosin β4 on spinal cord injury in the rat.\" \u003ci\u003eNeuropharmacology\u003c\/i\u003e 85 (2014): 408-416.\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25613458\/\"\u003eChopp, Michael, and Zheng Gang Zhang. \"Thymosin β4 as a restorative\/regenerative therapy for neurological injury and neurodegenerative diseases.\" \u003ci\u003eExpert opinion on biological therapy\u003c\/i\u003e 15.sup1 (2015): 9-12.\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30063849\/\"\u003eDubé, Karina N., and Nicola Smart. \"Thymosin β4 and the vasculature: multiple roles in development, repair and protection against disease.\" \u003ci\u003eExpert opinion on biological therapy\u003c\/i\u003e 18.sup1 (2018): 131-139.\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22653616\/\"\u003eSong, Ran, et al. \"Association between serum thymosin β4 levels of rheumatoid arthritis patients and disease activity and response to therapy.\" \u003ci\u003eClinical rheumatology\u003c\/i\u003e 31 (2012): 1253-1258.\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15037013\/\"\u003ePhilp, D., A. L. Goldstein, and H. K. Kleinman. \"Thymosin β4 promotes angiogenesis, wound healing, and hair follicle development.\" \u003ci\u003eMechanisms of ageing and development\u003c\/i\u003e 125.2 (2004): 113-115.\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0928425797894806\"\u003eSeiwerth, Sven, et al. \"BPC 157's effect on healing.\" \u003ci\u003eJournal of Physiology-Paris\u003c\/i\u003e 91.3-5 (1997): 173-178.\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23782145\/\"\u003eSeiwerth, Sven, et al. \"BPC 157 and blood vessels.\" \u003ci\u003eCurrent pharmaceutical design\u003c\/i\u003e 20.7 (2014): 1121-1125.\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0167011509002341\"\u003eTudor, Mario, et al. \"Traumatic brain injury in mice and pentadecapeptide BPC 157 effect.\" \u003ci\u003eRegulatory peptides\u003c\/i\u003e 160.1-3 (2010): 26-32.\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25995620\/\"\u003eHuang, Tonglie, et al. \"Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro.\" \u003ci\u003eDrug design, development and therapy\u003c\/i\u003e (2015): 2485-2499.\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21030672\/\"\u003eChang, Chung-Hsun, et al. \"The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.\" \u003ci\u003eJournal of applied physiology\u003c\/i\u003e 110.3 (2011): 774-780.\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29998800\/\"\u003eSeiwerth, Sven, et al. \"BPC 157 and standard angiogenic growth factors. Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing.\" \u003ci\u003eCurrent pharmaceutical design\u003c\/i\u003e 24.18 (2018): 1972-1989.\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eTesting Docs\u003c\/h2\u003e\n\u003cp class=\"attachment-restriction-msg\"\u003e\u003c\/p\u003e\u003cdiv class=\"wcpoa_attachment\"\u003e\u003ch4 class=\"wcpoa_attachment_name  \"\u003e\u003ca class=\"wcpoa_title_with_link\" href=\"https:\/\/edgepeptides.com\/bpc-157-tb-500-blend-10mg-10-vial-box\/?attachment_id=6727\u0026amp;download_file=6s6db6kp4d4wg\" target=\"_blank\"\u003e BPC-157 + TB-500 10 mg Blend Janoshik Test (2025)\u003c\/a\u003e\u003c\/h4\u003e\u003c\/div\u003e\u003cdiv class=\"wcpoa_attachment\"\u003e\u003ch4 class=\"wcpoa_attachment_name  \"\u003e\u003ca class=\"wcpoa_title_with_link\" href=\"https:\/\/edgepeptides.com\/bpc-157-tb-500-blend-10mg-10-vial-box\/?attachment_id=9052\u0026amp;download_file=49b6mk9n7r8nl\" target=\"_blank\"\u003e BPC-157 + TB-500 10 mg Blend Janoshik (March 2026)\u003c\/a\u003e\u003c\/h4\u003e\u003c\/div\u003e","brand":"Edge Peptides","offers":[{"title":"Default Title","offer_id":43288750620761,"sku":"BPCTB10","price":400.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0661\/2212\/1305\/files\/bpc-157-tb-500-10mg-blend-peptide-vial.png?v=1778079750","url":"https:\/\/edgepep.com\/products\/bpc-157-tb-500-blend-10mg-10-vial-box","provider":"EDGE PEP","version":"1.0","type":"link"}